De Priest et al v. Walgreen Co. et al
De Priest, Hannah De Priest, Frizell Johnson and Ruben Varela |
Walgreen Co, Walgreen Co., Publix Super Markets, Inc., Kenvue, Inc., McNeil Consumer Healthcare, Procter & Gamble Company, CVS Pharmacy, Inc. and Glaxosmithkline LLC |
ILN/1:23-CV-14060 |
September 25, 2023 |
Judicial Panel on Multidistrict Litigation |
Jorge L Alonso |
Other |
Docket Report
This docket was last retrieved on November 6, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 22 NOTICE OF WAIVER OF ORAL ARGUMENT re: pldg. (58 in CAE/2:23-cv-01965, 14 in LAE/2:23-cv-05273, 38 in NJ/2:23-cv-20370), ( #1 in MDL No. 3089), ( 166 in MDL No. 3089) Filed by Jay P Lefkowitz on behalf of Defendants HALEON, PLC, #et al.GlaxoSmithKline LLC, GlaxoSmithKline Consumer Heathcare Holdings (US) LLC, GSK CONSUMER HEALTHCARE, INC., GSK Plc, Haleon US Capital LLC, Pfizer, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3089 et al. (Lefkowitz, Jay) Modified on 11/7/2023 (RH). ADDED MDL LINK |
Filing 21 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( #1 in MDL No. 3089), ( 166 in MDL No. 3089) Filed by Hannah Y. Chanoine on behalf of Defendant JOHNSON & JOHNSON CONSUMER INC. (Attachments: #1 Schedule of Actions, #2 Certificate of Service) Associated Cases: MDL No. 3089 et al. (Chanoine, Hannah) Modified on 11/7/2023 (RH). ADDED MDL LINK |
Filing 20 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (58 in CAE/2:23-cv-01965, 21 in LAE/2:23-cv-05353, 166 in MDL No. 3089, 38 in NJ/2:23-cv-20370), (6 in CAN/4:23-cv-04875, 2 in ILN/1:23-cv-14060, 4 in ILN/1:23-cv-14155, 3 in ILN/1:23-cv-14404, 9 in OR/3:23-cv-01355, 5 in PAE/2:23-cv-03663, 18 in PAE/2:23-cv-03783, 4 in RI/1:23-cv-00403, 9 in WAW/2:23-cv-01481), (4 in CAN/4:23-cv-05128, 4 in NM/1:23-cv-00883), (1 in ILN/1:23-cv-13998, 2 in ILN/1:23-cv-14015, 2 in MN/0:23-cv-02915, 8 in PAE/2:23-cv-03874), ( #1 in MDL No. 3089) Filed by Sara K. Thompson on behalf of Defendants CVS Pharmacy, Inc., #et al.Walgreen Co., Target Corporation, CVS Health Corporation, Walgreens Boots Alliance, Inc., #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, CAN/4:23-cv-04875, CAN/4:23-cv-05128, ILN/1:23-cv-13998, ILN/1:23-cv-14015, ILN/1:23-cv-14060, ILN/1:23-cv-14155, ILN/1:23-cv-14404, ILN/1:23-cv-14558, ILS/3:23-cv-03494, LAE/2:23-cv-05353, MN/0:23-cv-02915, MOE/4:23-cv-01342, NJ/2:23-cv-20370, NM/1:23-cv-00883, OR/3:23-cv-01355, PAE/2:23-cv-03663, PAE/2:23-cv-03783, PAE/2:23-cv-03874, RI/1:23-cv-00403, SC/2:23-cv-04727, WAW/2:23-cv-01481 (Thompson, Sara) Modified on 11/7/2023 (RH). DELETED DUPLICATE PARTIES NAMES |
Filing 19 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (58 in CAE/2:23-cv-01965, 13 in FLM/2:23-cv-00727, 11 in FLN/3:23-cv-24250, 14 in LAE/2:23-cv-05273, 11 in LAE/2:23-cv-05274, 21 in LAE/2:23-cv-05353, #166 in MDL No. 3089, 38 in NJ/2:23-cv-20370, 12 in NYE/2:23-cv-06870), (72 in CAE/2:23-cv-01965, 7 in CAN/3:23-cv-04909, 12 in CAN/4:23-cv-05128, 15 in FLM/2:23-cv-00727, 12 in FLN/3:23-cv-24250, 4 in FLN/3:23-cv-24628, 3 in FLS/1:23-cv-23939, 9 in ILN/1:23-cv-13840, 8 in ILN/1:23-cv-13926, 14 in ILN/1:23-cv-14060, 19 in ILN/1:23-cv-14404, 15 in LAE/2:23-cv-05273, 13 in LAE/2:23-cv-05274, 24 in LAE/2:23-cv-05353, 2 in LAE/2:23-cv-05846, #230 in MDL No. 3089, 22 in MOW/4:23-cv-00663, 22 in MOW/5:23-cv-06120, 41 in NJ/2:23-cv-20370, 6 in NJ/3:23-cv-20895, 10 in NM/1:23-cv-00883, 15 in NYE/2:23-cv-06870, 9 in OHS/1:23-cv-00590, 13 in OHS/1:23-cv-00607, 11 in OHS/1:23-cv-00613, 8 in OHS/1:23-cv-00623, 16 in OR/3:23-cv-01355, 35 in PAE/2:23-cv-03783, 18 in PAE/2:23-cv-03856, 8 in PAE/2:23-cv-03874, 4 in PAE/2:23-cv-03899, 16 in WAW/2:23-cv-01481) Filed by Andrew Soukup on behalf of Defendant The Procter & Gamble Company (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3089 et al. (Soukup, Andrew) |
Filing 18 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3089) -- Identifying Corporate Parent Kenvue, Inc., Corporate Parent JNTL Holdings 2, Inc. for JOHNSON & JOHNSON CO NSUMER INC.. (Attachments: #1 Schedule of Actions, #2 Certificate of Service) Associated Cases: MDL No. 3089 et al. (Chanoine, Hannah) |
Filing 17 NOTICE OF APPEARANCE re: pldg.( 45 in MDL No. 3089, 120 in MDL No. 3089, 141 in MDL No. 3089, 51 in MDL No. 3089, 49 in MDL No. 3089, 173 in MDL No. 3089, 233 in MDL No. 3089, 236 in MDL No. 3089, 195 in MDL No. 3089, 199 in MDL No. 3089, 181 in MDL No. 3089, 205 in MDL No. 3089, 82 in MDL No. 3089, 122 in MDL No. 3089, 215 in MDL No. 3089, 101 in MDL No. 3089, 222 in MDL No. 3089) Filed by Hannah Y. Chanoine on behalf of Defendant JOHNSON & JOHNSON CONSUMER INC. (Attachments: #1 Schedule of Actions, #2 Certificate of Service) Associated Cases: MDL No. 3089 et al. (Chanoine, Hannah) Modified on 11/3/2023 (JC). ADDED MDL LINKS |
Filing 16 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #1 in MDL No. 3089) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Pa nel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel Tiffaney D. Pete on 11/2/2023. Associated Cases: MDL No. 3089 et al. (JC) |
Filing 15 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (5 in ARW/5:23-cv-05165, 72 in CAE/2:23-cv-01965, 12 in CAN/3:23-cv-04807, 5 in CAN/3:23-cv-04817, 7 in CAN/3:23-cv-04909, 23 in CAN/4:23-cv-04875, 12 in CAN/4:23-cv-05128, 15 in FLM/2:23-cv-00727, 2 in FLM/8:23-cv-02226, 12 in FLN/3:23-cv-24250, 11 in FLN/3:23-cv-24588, 4 in FLN/3:23-cv-24628, 3 in FLS/1:23-cv-23939, 11 in ILN/1:23-cv-13796, 9 in ILN/1:23-cv-13840, 6 in ILN/1:23-cv-13843, 8 in ILN/1:23-cv-13879, 8 in ILN/1:23-cv-13926, 1 in ILN/1:23-cv-13998, 2 in ILN/1:23-cv-14015, 14 in ILN/1:23-cv-14060, 11 in ILN/1:23-cv-14155, 19 in ILN/1:23-cv-14404, 11 in KS/2:23-cv-02426, 16 in KS/2:23-cv-02430, 15 in LAE/2:23-cv-05273, 13 in LAE/2:23-cv-05274, 24 in LAE/2:23-cv-05353, 2 in LAE/2:23-cv-05846, #230 in MDL No. 3089, 10 in MN/0:23-cv-02862, 2 in MN/0:23-cv-02915, 22 in MOW/4:23-cv-00663, 22 in MOW/5:23-cv-06120, 41 in NJ/2:23-cv-20370, 2 in NJ/2:23-cv-20444, 13 in NJ/2:23-cv- 20480, 11 in NJ/2:23-cv-20529, 11 in NJ/2:23-cv-20552, 2 in NJ/2:23-cv-20962, 8 in NJ/2:23-cv-21051, 11 in NJ/3:23-cv-20379, 13 in NJ/3:23-cv-20478, 7 in NJ/3:23-cv-20551, 7 in NJ/3:23-cv-20558, 2 in NJ/3:23-cv-20816, 2 in NJ/3:23-cv-20818, 6 in NJ/3:23-cv-20895, 10 in NM/1:23-cv-00883, 11 in NYE/1:23-cv-06936, 10 in NYE/1:23-cv-07311, 9 in NYE/1:23-cv-07395, 11 in NYE/2:23-cv-06825, 15 in NYE/2:23-cv-06870, 9 in OHS/1:23-cv-00590, 13 in OHS/1:23-cv-00607, 11 in OHS/1:23-cv-00613, 8 in OHS/1:23-cv-00623, 16 in OR/3:23-cv-01355, 16 in PAE/2:23-cv-03663, 35 in PAE/2:23-cv-03783, 18 in PAE/2:23-cv-03856, 8 in PAE/2:23-cv-03874, 4 in PAE/2:23-cv-03899, 11 in RI/1:23-cv-00403, 16 in WAW/2:23-cv-01481, 4 in WAW/2:23-cv-01606) Filed by Defendant The Procter & Gamble Company -- Associated Cases: MDL No. 3089 et al. (Soukup, Andrew) |
Filing 14 JOINT RESPONSE IN SUPPORT -- (re: pldg. ( #1 in MDL No. 3089) ) Filed by Defendants PROCTER & GAMBLE, Albertsons Companies, Inc., Amazon.com, Inc.,Associated Wholesale Grocers, Inc., Valu Merchandisers Company, Bayer HealthCare LLC, CVS Pharmacy, Inc., Target Corp., Walgreen Co., GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, Haleon US Capital LLC, Johnson & Johnson Consumer Inc., RB Health (US) LLC, Walmart Inc. and Wal-Mart Stores East, LP. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3089 et al. (Soukup, Andrew) Modified on 10/26/2023 (JC). EDITED EVENT TYPE, ADDED PARTY NAMES |
Filing 13 CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( 148 in MDL No. 3089, 48 in CAE/2:23-cv-01965, 7 in ILN/1:23-cv-14060, 6 in ILN/1:23-cv-14155, 8 in ILN/1:23-cv-14404, 35 in NJ/2:23-cv-20370, 11 in OR/3:23-cv-01355, 10 in PAE/2:23-cv-03663, 23 in PAE/2:23-cv-03783, 11 in WAW/2:23-cv-01481) Filed by Defendants Walgreen Co. and Walgreens Boots Alliance, Inc. -- Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, ILN/1:23-cv-14060, ILN/1:23-cv-14155, ILN/1:23-cv-14404, NJ/2:23-cv-20370, OR/3:23-cv-01355, PAE/2:23-cv-03663, PAE/2:23-cv-03783, WAW/2:23-cv-01481 (Thompson, Sara) Modified on 10/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 12 CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( 145 in MDL No. 3089, 45 in CAE/2:23-cv-01965, 10 in CAN/4:23-cv-04875, 6 in ILN/1:23-cv-14060, 7 in ILN/1:23-cv-14404, , 6 in RI/1:23-cv-00403) Filed by Defendant CVS Pharmacy, Inc. -- Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, CAN/4:23-cv-04875, ILN/1:23-cv-14060, ILN/1:23-cv-14404, RI/1:23-cv-00403 (Thompson, Sara) Modified on 10/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 11 CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( 153 in MDL No. 3089, 85 in MDL No. 3089, 29 in CAE/2:23-cv-01965, 2 in ILN/1:23-cv-14155, 19 in NJ/2:23-cv-20370, 7 in OR/3:23-cv-01355, 9 in PAE/2:23-cv-03783, 7 in WAW/2:23-cv-01481) Filed by Defendant Walgreen Co. -- Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, ILN/1:23-cv-14060, ILN/1:23-cv-14155, ILN/1:23-cv-14404, NJ/2:23-cv-20370, OR/3:23-cv-01355, PAE/2:23-cv-03663, PAE/2:23-cv-03783, WAW/2:23-cv-01481 (Thompson, Sara) Modified on 10/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 10 CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( 149 in MDL No. 3089, 80 in MDL No. 3089, 45 in CAE/2:23-cv-01965, 10 in CAN/4:23-cv-04875, 6 in ILN/1:23-cv-14060, 7 in ILN/1:23-cv-14404, 6 in RI/1:23-cv-00403) Filed by Defendant CVS Pharmacy, Inc. -- Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, CAN/4:23-cv-04875, ILN/1:23-cv-14060, ILN/1:23-cv-14404, RI/1:23-cv-00403 (Thompson, Sara) Modified on 10/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 9 CORPORATE DISCLOSURE STATEMENT (AMENDED) - re: pldg. (29 in CAE/2:23-cv-01965, 2 in ILN/1:23-cv-14155, 85 in MDL No. 3089, 19 in NJ/2:23-cv-20370, 7 in OR/3:23-cv-01355, 9 in PAE/2:23-cv-03783, 7 in WAW/2:23-cv-01481) Identifying Corporate Parent Walgreens Boots Alliance, Inc. a/k/a Walgreens, Co. for Walgreen Co. (Attachments: #1 Exhibit A - Schedule of Actions, #2 Exhibit B - Proof of Service) Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, ILN/1:23-cv-14060, ILN/1:23-cv-14155, ILN/1:23-cv-14404, NJ/2:23-cv-20370, OR/3:23-cv-01355, PAE/2:23-cv-03663, PAE/2:23-cv-03783, WAW/2:23-cv-01481 (Thompson, Sara) Modified on 10/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 8 CORPORATE DISCLOSURE STATEMENT (AMENDED) - re: pldg. (25 in CAE/2:23-cv-01965, 80 in MDL No. 3089, 2 in RI/1:23-cv-00403) Identifying Corporate Parent CVS Health Corporation for CVS Pharmacy, Inc. (Attachments: #1 Exhibit A - Schedule of Actions, #2 Exhibit B - Proof of Service) Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, CAN/4:23-cv-04875, ILN/1:23-cv-14060, ILN/1:23-cv-14404, RI/1:23-cv-00403 (Thompson, Sara) Modified on 10/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 7 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( 84 in MDL No. 3089, #1 in MDL No. 3089) Filed by Sara K. Thompson on behalf of Defendants Walgreen Co. and Walgreens Boots Alliance, Inc. (Attachments: #1 Exhibit A - Schedule of Actions, #2 Exhibit B - Proof of Service) Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, ILN/1:23-cv-14060, ILN/1:23-cv-14155, ILN/1:23-cv-14404, NJ/2:23-cv-20370, OR/3:23-cv-01355, PAE/2:23-cv-03663, PAE/2:23-cv-03783, WAW/2:23-cv-01481 (Thompson, Sara) Modified on 10/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES, EDITED EVENT TYPE, ADDED MDL LINK |
Filing 6 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( 79 in MDL No. 3089, #1 in MDL No. 3089) Filed by Sara K. Thompson on behalf of Defendant CVS Pharmacy, Inc. (Attachments: #1 Exhibit A - Schedule of Actions, #2 Exhibit B - Proof of Service) Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, CAN/4:23-cv-04875, ILN/1:23-cv-14060, ILN/1:23-cv-14404, RI/1:23-cv-00403 (Thompson, Sara) Modified on 10/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES , EDITED EVENT TYPE, ADDED MDL LINK |
Filing 5 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (32 in CAE/2:23-cv-01965, 1 in ILN/1:23-cv-14060, 1 in ILN/1:23-cv-14404, 89 in MDL No. 3089, 22 in NJ/2:23-cv-20370, 1 in NYE/1:23-cv-07311, 1 in OHS/1:23-cv-00607, 12 in PAE/2:23-cv-03783, 5 in PAE/2:23-cv-03856), (33 in CAE/2:23-cv-01965, 3 in CAN/4:23-cv-04875, 91 in MDL No. 3089), (1 in ILN/1:23-cv-13843, 1 in KS/2:23-cv-02430, 93 in MDL No. 3089) Filed by Defendants HALEON, PLC, GlaxoSmithKline LLC, GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC, GSK CONSUMER HEALTHCARE, INC. GSK Plc, Haleon US Capital LLC, Pfizer, Inc. -- Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, CAN/4:23-cv-04875, ILN/1:23-cv-13843, ILN/1:23-cv-14060, ILN/1:23-cv-14404, KS/2:23-cv-02430, LAE/2:23-cv-05273, NJ/2:23-cv-20370, NJ/3:23-cv-20478, NYE/1:23-cv-07311, OHS/1:23-cv-00607, PAE/2:23-cv-03663, PAE/2:23-cv-03783, PAE/2:23-cv-03856 (Lefkowitz, Jay) Modified on 10/11/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 4 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( #2 in MDL No. 3089), ( 120 in MDL No. 3089), ( #1 in MDL No. 3089, 88 in MDL No. 3089)) Filed by Jay P Lefkowitz on behalf of Defendants HALEON, PLC, GlaxoSmithKline LLC, GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC, GSK CONSUMER HEALTHCARE, INC. GSK Plc, Haleon US Capital LLC, Pfizer, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, CAN/4:23-cv-04875, ILN/1:23-cv-13843, ILN/1:23-cv-14060, ILN/1:23-cv-14404, KS/2:23-cv-02430, LAE/2:23-cv-05273, NJ/2:23-cv-20370, NJ/3:23-cv-20478, NYE/1:23-cv-07311, OHS/1:23-cv-00607, PAE/2:23-cv-03663, PAE/2:23-cv-03783, PAE/2:23-cv-03856 (Lefkowitz, Jay) Modified on 10/11/2023 (JC). ADDED MDL LINK, REMOVED DUPLICATE PARTY NAMES |
Filing 3 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( #135 in MDL No. 3089) ) -- Before the Panel is the Unopposed Motion of Defendants Walmart Inc., The Procter & Gamble Company, et al., for Extension of Time to File Response. Defendants represent, inter alia, that additional time is warranted so that they may consolidate their views into a single response paper. The motion is GRANTED AS TO ALL PARTIES. Responses shall be filed on or before 10/25/2023. Defendants shall, to the maximum extent practicable, file a single consolidated brief. Movants' Reply, if any, shall be filed on or before 11/1/2023.No further extensions will be granted to any party absent extraordinary circumstances. Signed by Clerk of the Panel Tiffaney D Pete on 10/10/2023. Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, CAN/3:23-cv-04807, CAN/3:23-cv-04817, CAN/3:23-cv-04909, CAN/4:23-cv-04875, FLM/2:23-cv-00727, FLN/3:23-cv-24250, FLN/3:23-cv-24588, ILN/1:23-cv-13796, ILN/1:23-cv-13840, ILN/1:23-cv-13843, ILN/1:23-cv-13879, ILN/1:23-cv-13926, ILN/1:23-cv-14060, ILN/1:23-cv-14155, ILN/1:23-cv-14404, KS/2:23-cv-02426, KS/2:23-cv-02430, LAE/2:23-cv-05273, LAE/2:23-cv-05274, LAE/2:23-cv-05353, MN/0:23-cv-02862, MOW/4:23-cv-00663, MOW/5:23-cv-06120, NJ/2:23-cv-20370, NJ/2:23-cv-20480, NJ/2:23-cv-20529, NJ/2:23-cv-20552, NJ/3:23-cv-20379, NJ/3:23-cv-20478, NJ/3:23-cv-20551, NJ/3:23-cv-20558, NJ/3:23-cv-20895, NYE/1:23-cv-06936, NYE/1:23-cv-07311, NYE/1:23-cv-07395, NYE/2:23-cv-06825, NYE/2:23-cv-06870, OHS/1:23-cv-00590, OHS/1:23-cv-00607, OHS/1:23-cv-00613, OHS/1:23-cv-00623, OR/3:23-cv-01355, PAE/2:23-cv-03663, PAE/2:23-cv-03783, PAE/2:23-cv-03856, RI/1:23-cv-00403, WAW/2:23-cv-01481 (DLD) |
Filing 2 MOTION FOR EXTENSION OF TIME TO FILE RESPONSE re: pldg. ( #2 in MDL No. 3089), ( #1 in MDL No. 3089) Filed by Livia M. Kiser on behalf of Defendants Walmart Inc., The Procter & Gamble Company, Bayer Healthcare, LLC, Amazon.com, Inc., RB Health (US) LLC, Albertsons Companies, Inc. Target Corporation, Rite Aid Corporation, CVS Pharmacy, Inc., Walgreen Co., Walgreens Boots Alliance, Kenvue Inc., Haleon US Capital LLC, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, GSK Consumer Healthcare, Inc., GlaxoSmithKline LLC and Pfizer Inc. Inc. Associated Cases: MDL No. 3089 et al. (Kiser, Livia) Modified on 10/11/2023 (JC). REMOVED DUPLICATE PARTIES |
Filing 1 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #2 in MDL No. 3089), ( #1 in MDL No. 3089) -- Identifying Other Affiliate GlaxoSmithKline Finance plc, Other Affiliate GlaxoSmithKline Holdings Limited, Other Affiliate GSK Finance (No 2) Limited, Other Affiliate GlaxoSmithKline Holdings (Americas) Inc, Other Affiliate GSK plc, Non-Party/Financial Interest JPMorgan Chase Bank, N.A. for GLAXOSMITHKLINE LLC. (Attachments: #1 Attachment A- Short Case Captions, #2 Attachment B- Ownership Breakdown, #3 Proof of Service) Associated Cases: MDL No. 3089, CAE/2:23-cv-01965, ILN/1:23-cv-14060, ILN/1:23-cv-14404, NJ/2:23-cv-20370, NYE/1:23-cv-07311, OHS/1:23-cv-00607, PAE/2:23-cv-03783, PAE/2:23-cv-03856 (Lefkowitz, Jay) Modified on 10/6/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.